Ixazomib inhibits myeloma cell proliferation by targeting UBE2K.
Wang Q, Dong Z, Su J, Huang J, Xiao P, Tian L, Chen Y, Ma L, Chen X.
Wang Q, et al. Among authors: huang j.
Biochem Biophys Res Commun. 2021 Apr 16;549:1-7. doi: 10.1016/j.bbrc.2021.02.048. Epub 2021 Feb 26.
Biochem Biophys Res Commun. 2021.
PMID: 33647537
Free article.